|
|
|
|
|
Tennessee
(State
or other jurisdiction
of
incorporation)
|
|
0—24425
(Commission
File
Number)
|
|
54-1684963
(IRS
Employer
Identification
Number)
|
|
|
|
501
Fifth Street, Bristol, Tennessee
(Address
of principal executive offices)
|
|
37620
(Zip
Code)
|
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Exhibit
Number
|
Description
of Exhibit
|
10.1
|
Director
Compensation Policy for Non-Employee Directors of King Pharmaceuticals,
Inc., as approved by the Board of Directors on February 13, 2004
and
amended on July 22, 2005, February 22, 2006 and August 2,
2006.
|
Date:
August 8, 2006
|
KING
PHARMACEUTICALS, INC.
|
By:
/s/ Joseph
Squicciarino
Joseph
Squicciarino
Chief
Financial Officer
|